Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoid Bolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBT THCV has been researched for a variety of potential benefits VANCOUVER,… Read More
For UBC researchers and scientists focusing on innovations that will advance the future of our world Lab2Launch supports UBC researchers and scientists who plan to build, or are building, a deep… Read More
New scientific advisors bring expertise in cell therapy development, surgery & transplantation, liver disease, diabetes, and biomaterials VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioengineered… Read More
Treatment with targeted therapies Tafinlar + Mekinist resulted in 47% ORR versus chemotherapy (11%) and reduced risk of progression or death by 69%, showing significant efficacy improvement in patients ages… Read More
CALGARY, AB & MOUNTAIN VIEW, CA – Willow Biosciences Inc. (“Willow” or the “Company”) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable ingredients… Read More
